Holdings of Simplify Propel Opportunities ETF
Simplify Exchange Traded Funds · Original filing · Compare with another fund · Report an error
- Net assets
- 69.4M $ including 67.5M $ in equities, 97.3 %
- Positions
- 37 in 7 countries
- Top ten
- 73.2 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Plains GP Holdings LP | 1,272,360 | 30.9M $ | 44.55 % |
| 2 | ACHIEVE LIFE SCIENCES INC | 1,184,512 | 3.5M $ | 5.02 % |
| 3 | Phathom Pharmaceuticals Inc | 262,386 | 2.9M $ | 4.20 % |
| 4 | Delcath Systems Inc | 261,126 | 2.4M $ | 3.49 % |
| 5 | Abeona Therapeutics Inc | 500,342 | 2.2M $ | 3.23 % |
| 6 | Celldex Therapeutics Inc | 68,994 | 2.2M $ | 3.16 % |
| 7 | Milestone Pharmaceuticals Inc | 1,506,405 | 1.8M $ | 2.58 % |
| 8 | Oculis Holding AG | 66,667 | 1.8M $ | 2.56 % |
| 9 | LeonaBio Inc | 149,279 | 1.5M $ | 2.21 % |
| 10 | Corcept Therapeutics Inc | 37,763 | 1.5M $ | 2.20 % |
| 11 | Kyverna Therapeutics Inc | 173,106 | 1.5M $ | 2.15 % |
| 12 | Inventiva SACA | 227,923 | 1.3M $ | 1.82 % |
| 13 | Viridian Therapeutics Inc | 56,231 | 1.1M $ | 1.59 % |
| 14 | Aquestive Therapeutics Inc | 234,279 | 972.3K $ | 1.40 % |
| 15 | Vor BioPharma Inc | 53,510 | 954.6K $ | 1.38 % |
| 16 | Orchestra BioMed Holdings Inc | 219,387 | 932.4K $ | 1.34 % |
| 17 | Zevra Therapeutics Inc | 96,246 | 897K $ | 1.29 % |
| 18 | Compass Pathways plc | 159,052 | 879.6K $ | 1.27 % |
| 19 | Trevi Therapeutics Inc | 65,412 | 780.4K $ | 1.13 % |
| 20 | Ocular Therapeutix Inc | 90,000 | 762.3K $ | 1.10 % |
| 21 | SAB Biotherapeutics Inc | 187,230 | 717.1K $ | 1.03 % |
| 22 | Upstream Bio Inc | 77,793 | 700.1K $ | 1.01 % |
| 23 | EyePoint Inc | 53,526 | 690K $ | 0.99 % |
| 24 | 4D Molecular Therapeutics Inc | 70,430 | 655.7K $ | 0.95 % |
| 25 | Palisade Bio Inc | 350,000 | 612.5K $ | 0.88 % |
| 26 | Zealand Pharma A/S | 12,330 | 568.8K $ | 0.82 % |
| 27 | KALARIS THERAPEUTICS INC | 87,426 | 504.4K $ | 0.73 % |
| 28 | IMMUNIC INC | 438,932 | 487.2K $ | 0.70 % |
| 29 | Coherus Oncology Inc | 253,140 | 427.8K $ | 0.62 % |
| 30 | Akero Therapeutics Inc | 145,609 | 426.6K $ | 0.62 % |
| 31 | Corvus Pharmaceuticals Inc | 20,242 | 296.1K $ | 0.43 % |
| 32 | Ovid therapeutics Inc | 130,813 | 290.4K $ | 0.42 % |
| 33 | Artiva Biotherapeutics Inc | 23,230 | 149.6K $ | 0.22 % |
| 34 | CONNECT BIOPHARMA HOLDINGS LTD | 53,375 | 139.8K $ | 0.20 % |
| 35 | Chinook Therapeutics Inc | 25,000 | 2.5K $ | 0.00 % |
| 36 | Eiger BioPharmaceuticals Inc | 90,000 | 900 $ | 0.00 % |
| 37 | ACHIEVE LIFE SCIENCES, INC. | 966,667 | 1 $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 90.5 %
- Canada 2.7 %
- Switzerland 2.6 %
- France 1.9 %
- United Kingdom 1.3 %
- Denmark 0.8 %
- Cayman Islands 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 31 | 61.1M $ | 90.49 % |
| 2 | Canada | 1 | 1.8M $ | 2.66 % |
| 3 | Switzerland | 1 | 1.8M $ | 2.63 % |
| 4 | France | 1 | 1.3M $ | 1.87 % |
| 5 | United Kingdom | 1 | 879.6K $ | 1.30 % |
| 6 | Denmark | 1 | 568.8K $ | 0.84 % |
| 7 | Cayman Islands | 1 | 139.8K $ | 0.21 % |
Cite this page
Titelia. "Holdings of Simplify Propel Opportunities ETF". https://titelia.com/en/funds/S000078061